Catch up on what happened in optometry during the week of February 19-February 23.
Catch up with what Optometry Times shared this week:
By Lynda Charters and Carl R. Regillo, MD
With the current focus on stopping the progression to geographic atrophy (GA) associated with age-related macular degeneration (AMD), physicians and researchers are fine-tuning the identification of the various disease stages, management scenarios, and treatment considerations for this patient population.
By Emily Kaiser Maharjan, Assistant Managing Editor, Andrew S. Morgenstern, OD, FAAO, FNAP, and Jordana Joy, Associate Editor
This spring, there is more to look forward to than just warmer weather. The International Keratoconus Academy (IKA) is holding its second annual Keratoconus Symposium, running from May 18 and 19 in Bethesda, Maryland. IKA President and Cofounder Andrew S. Morgenstern, OD, FAAO, FNAP sat down with Optometry Times to detail what's to come at this year's event, as well as shed light on keratoconus and technological advancements to aid in treatments and diagnosis.
By Lynda Charters and Cassie A. Ludwig, MD, MSc
Cassie A. Ludwig, MD, MSc, Assistant Professor of Ophthalmology, Stanford University, Stanford, CA, addressed the epidemic of myopia and its vitreoretinal complications at the Envision Summit in Puerto Rico.
By Jason E. Vice, PhD, OT, SCLV
As an occupational therapist working in low vision rehabilitation, I collaborate with a multidisciplinary team to provide the highest level of service possible to patients with visual impairments. Individuals of all ages can experience vision loss due to a variety of conditions—from eye disease to acquired brain injury. Our aim is to help patients maximize their remaining vision so they may participate as fully as possible in activities that are important to them.
By Jordana Joy, Associate Editor and Tracy Williams, OD, FAAO
In honor of Age-related Macular Degeneration (AMD) Awareness Month, Optometry Times sat down with R Tracy Williams, OD, FAAO, to chat about the significance of referring patients early for AMD concerns and the role that awareness plays in slowing the progression of low vision.